Kristine Toft Petersen

Kristine Toft Petersen is a Researcher at Aalborg University's Faculty of Health Sciences, based in the Infectious Diseases Department at Aalborg University Hospital. With 17 publications spanning 2018-2025, she maintains an active research profile focused on infectious disease dynamics, particularly regarding SARS-CoV-2 and COVID-19.

Her primary research interests include immunological biomarkers in severe infections, vaccine efficacy, antibody dynamics, and clinical predictors of disease outcomes. Her work examines lymphocyte trajectories in severe COVID-19, hospitalization risk factors, antibody development following vaccination, and therapeutic interventions including monoclonal antibodies. The fingerprint analysis of her publications shows strong emphasis on Severe Acute Respiratory Syndrome Coronavirus 2 (100%), COVID-19 (94%), Vaccine Efficacy (59%), Virus Nucleocapsid (48%), and Blood Plasma (36%).

Dr. Petersen's research demonstrates a clear progression from early pandemic clinical observations to sophisticated longitudinal studies of immune responses. Her most recent work (2025) focuses on global population studies of recovery patterns and lymphocyte dynamics, representing a maturation of her research program toward large-scale international collaborations.

• Active participant in STRIVE Network and TICO Trial Study Group
• Contributor to ACTIV-3/TICO Study Group
• Member of ENFORCE Study Group

Her publications in high-impact journals including Annals of Internal Medicine, The Lancet Microbe, and The Journal of Infectious Diseases have received attention from news outlets, social media (including 33 Mendeley readers for her 2025 Annals paper), and academic citations, demonstrating the relevance of her work to ongoing public health discussions.